Literature DB >> 6103935

Evidence for a direct anti-inflammatory action of calcitonin: inhibition of histamine-induced mouse pinnal oedema by porcine calcitonin.

R J Strettle, R F Bates, G A Buckley.   

Abstract

Porcine calcitonin (PCT) caused a potent inhibition of histamine-induced vascular leakage in the mouse pinna. These effects were observed at doses of PCT lower than those required to affect plasma calcium concentrations. In contrast PCT did not inhibit responses of the mouse pinna to 5-hydroxytryptamine despite observed falls in plasma calcium concentrations. It would appear that PCT inhibits histamine-induced oedema in the mouse by a direct action which may partially or fully explain the anti-inflammatory action of PCT, observed by other workers, in some acute inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103935     DOI: 10.1111/j.2042-7158.1980.tb12888.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin.

Authors:  Bryan R Becklund; Donald W Hansen; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

2.  Increase of pain threshold by calcitonin during electrical stimulation of the dental pulp. Investigations in healthy volunteers with regard to plasma concentration.

Authors:  K Welzel; D Welzel
Journal:  Schmerz       Date:  1989-09       Impact factor: 1.107

3.  Influence of pharmacological doses of calcitonin on serum beta 2 microglobulin concentration.

Authors:  H Mulder; H van Bolhuis; M A Naafs; P L Winckers
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

Review 4.  Calcitonin and its antinociceptive activity: animal and human investigations 1975-1992.

Authors:  P C Braga
Journal:  Agents Actions       Date:  1994-05

5.  Influence of calcitonin treatment on the osteocalcin concentration in the algodystrophy of bone.

Authors:  A Sawicki; P Szulc; T Sobczyk; J Goliszewski; P Garnier; R Labuszewski
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.